Skip to content

The influence of Eye Movement treatment on imagery in psychosis

The influence of Eye Movement treatment on imagery in psychosis - EMIPS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40995
Enrollment
20
Registered
2014-07-02
Start date
2014-07-16
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Psychotic disorders/ 2. Schizophrenia

Interventions

During the preparation phase of EMDR, various targets for treatment will be identified, which involve crucial upsetting memories/images related to the psychosis (see protocol for defined explanation

Sponsors

Altrecht GGZ (Den Dolder)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Outpatients with a diagnosis in the spectrum of psychotic disorders (Schizophrenia of Schizoaffective, delusional or other psychotic disorder), will participate. Patients are diagnosed by psychiatrists in the mental health institution Altrecht. Classification is rendered by standard psychiatric interview by DSM IV criteria, Patients are between the age of 18 and 60 years, have an IQ above 75 and have no problems with the Dutch language.

Exclusion criteria

Exclusion criteria: People with severe or acute psychotic symptoms (with a PANNS score > 6) and people with dissociative disorders are also excluded. Patients with dissociative disorders are referred to a department for care for dissociative disorders. Dissociation in terms of PTSD are excluded from the trial by the therapist who performs the intake for the treatment. If PTSD is diagnosed, then a PTSD treatment is indicated and the patient is exlcluded from the study. All patients take antipsychotic medication, and there will be no policies of changing the medication in dose or sort during the study. IQ below 80 will be excluded. This is an overall estimation by the therapist who indicates for the study. In case of doubt the patient will not be included.

Design outcomes

Primary

MeasureTime frame
Emotionality and vividness of the imagey are rated on VASs that run from *0* (not at all) to *10* (extremely).

Secondary

MeasureTime frame
Perceived effectiveness. For each treatment condition, patients will be rated on 100 mm VASs the degree to which they think it will help them. VASs ranges from *0* (will not be helpful at all) to *100* (will be extremely helpful). Preference. Patients will indicate which of the three interventions they would prefer in their continuing treatment. Verbal elucidation of preference. Patients will be invited to elucidate their preference in one or more sentences

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)